NYSE:CHE Chemed (CHE) Stock Forecast, Price & News $513.90 -0.57 (-0.11%) (As of 09/26/2023 ET) Add Compare Share Share Today's Range$507.52▼$515.4550-Day Range$499.76▼$568.6152-Week Range$430.16▼$574.66Volume56,874 shsAverage Volume70,854 shsMarket Capitalization$7.75 billionP/E Ratio34.26Dividend Yield0.31%Price Target$593.00 ProfileProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Chemed MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside15.4% Upside$593.00 Price TargetShort InterestHealthy3.48% of Float Sold ShortDividend StrengthStrongBased on Four FactorsSustainability-0.33Upright™ Environmental ScoreNews Sentiment0.73Based on 4 Articles This WeekInsider TradingSelling Shares$2.07 M Sold Last QuarterProj. Earnings Growth16.74%From $19.12 to $22.32 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.3.05 out of 5 starsMedical Sector29th out of 963 stocksHome Health Care Services Industry2nd out of 7 stocks 2.5 Analyst's Opinion Consensus RatingChemed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $593.00, Chemed has a forecasted upside of 15.4% from its current price of $513.90.Amount of Analyst CoverageChemed has only been the subject of 1 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted3.48% of the float of Chemed has been sold short.Short Interest Ratio / Days to CoverChemed has a short interest ratio ("days to cover") of 7.1.Change versus previous monthShort interest in Chemed has recently decreased by 21.03%, indicating that investor sentiment is improving significantly. Previous Next 3.3 Dividend Strength Dividend YieldChemed has a dividend yield of 0.31%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthChemed has been increasing its dividend for 15 years.Dividend CoverageThe dividend payout ratio of Chemed is 10.67%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Chemed will have a dividend payout ratio of 7.17% next year. This indicates that Chemed will be able to sustain or increase its dividend. Previous Next 4.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreChemed has received a 80.32% net impact score from Upright. Chemed seems to create the most significant positive value in categories "Taxes", "Jobs", and "Meaning & joy". The positive contribution in the "Meaning & joy" impact category is mostly driven by its "Private hospice care", "Private home care for the elderly", and "Property water damage restoration" products. See details.Environmental SustainabilityThe Environmental Impact score for Chemed is -0.33. Previous Next 2.1 News and Social Media Coverage News SentimentChemed has a news sentiment score of 0.73. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Chemed this week, compared to 3 articles on an average week. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Chemed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,065,720.00 in company stock.Percentage Held by InsidersOnly 4.03% of the stock of Chemed is held by insiders.Percentage Held by Institutions94.25% of the stock of Chemed is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Chemed are expected to grow by 16.74% in the coming year, from $19.12 to $22.32 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Chemed is 34.26, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 116.76.Price to Earnings Ratio vs. SectorThe P/E ratio of Chemed is 34.26, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 109.83.Price to Earnings Growth RatioChemed has a PEG Ratio of 3.08. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioChemed has a P/B Ratio of 9.57. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Chemed (NYSE:CHE) StockChemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Read More CHE Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CHE Stock News HeadlinesSeptember 20, 2023 | americanbankingnews.comOncology Institute (NASDAQ:TOIIW) & Chemed (NYSE:CHE) Financial ContrastSeptember 18, 2023 | americanbankingnews.comZacks Research Comments on Chemed Co.'s Q3 2023 Earnings (NYSE:CHE)September 27, 2023 | Behind the Markets (Ad)New Breakthrough "Living Software" Has Been…New Breakthrough "Living Software" Has Been... Ukraine's "Secret Weapon" Against Russia The Washington Post Reports: "It's a big reason David is beating Goliath..." The Wall Street Journal Reports: "it's a technical revolution." Jeff Bezos Said: "It's in the realm of science fiction." Early investors can reap 5,633% gains on the small company revolutionizing warfare >>>September 14, 2023 | finance.yahoo.comChemed (CHE) Faces Macroeconomic Woes, Tough CompetitionAugust 26, 2023 | seekingalpha.comChemed - Showcasing Why It's So ReliableAugust 16, 2023 | msn.com80% of Israel's Ethiopian, Indian immigrants opt for religious education - reportAugust 15, 2023 | finance.yahoo.comOPCH vs. CHE: Which Stock Should Value Investors Buy Now?August 13, 2023 | msn.comChemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be OverlookedSeptember 27, 2023 | Behind the Markets (Ad)New Breakthrough "Living Software" Has Been…New Breakthrough "Living Software" Has Been... Ukraine's "Secret Weapon" Against Russia The Washington Post Reports: "It's a big reason David is beating Goliath..." The Wall Street Journal Reports: "it's a technical revolution." Jeff Bezos Said: "It's in the realm of science fiction." Early investors can reap 5,633% gains on the small company revolutionizing warfare >>>August 11, 2023 | msn.comChemed (CHE) Declares $0.40 DividendAugust 10, 2023 | seekingalpha.comChemed Corporation 2023 Q2 - Results - Earnings Call PresentationAugust 7, 2023 | finance.yahoo.comAre Chemed Corporation (NYSE:CHE) Investors Paying Above The Intrinsic Value?August 4, 2023 | marketwatch.comChemed Corp. Raises Quarterly Dividend by 5.3% >CHEAugust 4, 2023 | finance.yahoo.comChemed Corporation Declares Quarterly Dividend of 40 CentsAugust 1, 2023 | msn.comRBC Capital Maintains Chemed (CHE) Outperform RecommendationJuly 28, 2023 | nasdaq.comOppenheimer Maintains Chemed (CHE) Outperform RecommendationJuly 27, 2023 | finance.yahoo.comChemed (CHE) Reports Q2 Earnings: What Key Metrics Have to SayJuly 26, 2023 | washingtonpost.comChemed: Q2 Earnings SnapshotJuly 26, 2023 | markets.businessinsider.comChemed Corp. Q2 Income Retreats, misses estimatesJuly 26, 2023 | finance.yahoo.comChemed (CHE) Q2 Earnings and Revenues Lag EstimatesJuly 26, 2023 | finance.yahoo.comChemed Reports Second-Quarter 2023 ResultsJuly 26, 2023 | markets.businessinsider.comHere's what Wall Street expects from Chemed's earnings reportJuly 26, 2023 | msn.comChemed Non-GAAP EPS of $4.71 misses by $0.38, revenue of $554M misses by $8.54MJuly 21, 2023 | finance.yahoo.comChemed's (NYSE:CHE) 12% CAGR outpaced the company's earnings growth over the same five-year periodJuly 12, 2023 | finance.yahoo.comChemed To Report Second-Quarter 2023 Earnings July 26, Related Conference Call To Be Held On July 27June 30, 2023 | markets.businessinsider.comAddus Homecare (ADUS) Receives a Buy from Bank of America SecuritiesJune 5, 2023 | finance.yahoo.comHere's What Chemed's (NYSE:CHE) Strong Returns On Capital MeanSee More Headlines Receive CHE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter. Email Address CHE Company Calendar Last Earnings7/26/2023Ex-Dividend for 9/5 Dividend8/11/2023Dividend Payable9/05/2023Today9/27/2023Next Earnings (Estimated)10/30/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Home health care services Sub-IndustryHealth Care Services SectorMedical Current SymbolNYSE:CHE CUSIP16359R10 CIK19584 Webwww.chemed.com Phone(513) 762-6690Fax513-762-6590Employees14,167Year Founded1970Price Target and Rating Average Stock Price Forecast$593.00 High Stock Price Forecast$610.00 Low Stock Price Forecast$576.00 Forecasted Upside/Downside+15.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$15.00 Trailing P/E Ratio34.26 Forward P/E Ratio26.88 P/E Growth3.08Net Income$249.62 million Net Margins10.36% Pretax Margin13.73% Return on Equity34.65% Return on Assets20.25% Debt Debt-to-Equity RatioN/A Current Ratio1.11 Quick Ratio1.08 Sales & Book Value Annual Sales$2.19 billion Price / Sales3.54 Cash Flow$24.15 per share Price / Cash Flow21.28 Book Value$53.71 per share Price / Book9.57Miscellaneous Outstanding Shares15,077,000Free Float14,504,000Market Cap$7.75 billion OptionableOptionable Beta0.53 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for October 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Kevin J. McNamara (Age 69)CEO, Pres & Director Comp: $5.66MMr. David P. Williams (Age 62)Exec. VP & CFO Comp: $2.63MMr. Michael D. Witzeman CPA (Age 52)MBA, VP & Controller Comp: $985.01kMr. Spencer S. Lee (Age 67)Exec. VP Comp: $1.86MMr. Thomas C. Hutton (Age 72)VP & Director Mr. Nicholas Michael Westfall (Age 44)Exec. VP Comp: $2.05MMs. Lisa A. ReinhardVP, Chief Admin. Officer & Sec.Sherri WarnerDirector of Investor RelationsMr. Brian C. Judkins (Age 42)VP, Sec. & Chief Legal Officer More ExecutivesKey CompetitorsAmedisysNASDAQ:AMEDOption Care HealthNASDAQ:OPCHagilon healthNYSE:AGLStevanato GroupNYSE:STVNMedpaceNASDAQ:MEDPView All CompetitorsInsiders & InstitutionsCGC Financial Services LLCBought 241 shares on 9/13/2023Ownership: 0.002%Wolverine Trading LLCBought 700 shares on 8/23/2023Ownership: 0.000%Comerica BankBought 33,725 shares on 8/22/2023Ownership: 0.224%Virginia Retirement Systems ET ALBought 4,800 shares on 8/22/2023Ownership: 0.032%Osaic Holdings Inc.Sold 110 shares on 8/21/2023Ownership: 0.061%View All Insider TransactionsView All Institutional Transactions CHE Stock - Frequently Asked Questions Should I buy or sell Chemed stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CHE shares. View CHE analyst ratings or view top-rated stocks. What is Chemed's stock price forecast for 2023? 1 analysts have issued twelve-month target prices for Chemed's stock. Their CHE share price forecasts range from $576.00 to $610.00. On average, they expect the company's share price to reach $593.00 in the next twelve months. This suggests a possible upside of 15.4% from the stock's current price. View analysts price targets for CHE or view top-rated stocks among Wall Street analysts. How have CHE shares performed in 2023? Chemed's stock was trading at $510.43 at the beginning of 2023. Since then, CHE stock has increased by 0.7% and is now trading at $513.8950. View the best growth stocks for 2023 here. Are investors shorting Chemed? Chemed saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 511,700 shares, a decline of 21.0% from the August 15th total of 648,000 shares. Based on an average daily volume of 71,900 shares, the days-to-cover ratio is currently 7.1 days. Currently, 3.5% of the shares of the stock are sold short. View Chemed's Short Interest. When is Chemed's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, October 30th 2023. View our CHE earnings forecast. How were Chemed's earnings last quarter? Chemed Co. (NYSE:CHE) announced its earnings results on Wednesday, July, 26th. The company reported $4.71 earnings per share for the quarter, missing the consensus estimate of $5.09 by $0.38. The firm earned $553.80 million during the quarter, compared to analyst estimates of $562.54 million. Chemed had a trailing twelve-month return on equity of 34.65% and a net margin of 10.36%. The business's revenue was up 4.2% compared to the same quarter last year. During the same period in the previous year, the business earned $4.84 EPS. How often does Chemed pay dividends? What is the dividend yield for Chemed? Chemed announced a quarterly dividend on Friday, August 4th. Investors of record on Monday, August 14th will be given a dividend of $0.40 per share on Tuesday, September 5th. This represents a $1.60 annualized dividend and a yield of 0.31%. The ex-dividend date of this dividend is Friday, August 11th. This is an increase from the stock's previous quarterly dividend of $0.38. Read our dividend analysis for CHE. What ETFs hold Chemed's stock? ETFs with the largest weight of Chemed (NYSE:CHE) stock in their portfolio include VictoryShares THB Mid Cap ESG ETF (MDCP), Formidable Fortress ETF (KONG), First Trust Dorsey Wright Momentum & Low Volatility ETF (DVOL), Opus Small Cap Value Plus ETF (OSCV), Inspire Faithward Mid Cap Momentum ETF (GLRY), Natixis Vaughan Nelson Select ETF (VNSE), FIS Biblically Responsible Risk Managed ETF (PRAY) and Dividend Performers ETF (IPDP). Is Chemed a good dividend stock? Chemed (NYSE:CHE) pays an annual dividend of $1.60 per share and currently has a dividend yield of 0.31%. The company has been increasing its dividend for 15 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 10.67%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CHE will have a dividend payout ratio of 7.17% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for CHE. What guidance has Chemed issued on next quarter's earnings? Chemed issued an update on its FY 2023 earnings guidance on Wednesday, July, 26th. The company provided earnings per share guidance of $19.90-$20.10 for the period, compared to the consensus estimate of $20.92. The company issued revenue guidance of -. What is Kevin J. McNamara's approval rating as Chemed's CEO? 1 employees have rated Chemed Chief Executive Officer Kevin J. McNamara on Glassdoor.com. Kevin J. McNamara has an approval rating of 100% among the company's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Chemed own? Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX). What is Chemed's stock symbol? Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE." Who are Chemed's major shareholders? Chemed's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.39%), William Blair Investment Management LLC (3.72%), Kayne Anderson Rudnick Investment Management LLC (3.43%), Durable Capital Partners LP (3.03%), State Street Corp (2.94%) and Impax Asset Management Group plc (1.98%). Insiders that own company stock include David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee and Thomas P Rice. View institutional ownership trends. How do I buy shares of Chemed? Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Chemed's stock price today? One share of CHE stock can currently be purchased for approximately $513.90. How much money does Chemed make? Chemed (NYSE:CHE) has a market capitalization of $7.75 billion and generates $2.19 billion in revenue each year. The company earns $249.62 million in net income (profit) each year or $15.00 on an earnings per share basis. How many employees does Chemed have? The company employs 14,167 workers across the globe. How can I contact Chemed? Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The official website for the company is www.chemed.com. The company can be reached via phone at (513) 762-6690 or via fax at 513-762-6590. This page (NYSE:CHE) was last updated on 9/27/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemed Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.